ArticleContemporary clinical trials2025
Self-Management for Youth Living with Sickle Cell Disease (SMYLS): A study protocol for a multisite randomized controlled trial testing a behavioral, mHealth app.
Article in Contemporary clinical trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06035939 (Self-Management for Youth Living With Sickle Cell Disease), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Self-Management for Youth Living With Sickle Cell Disease: SMYLS Multi-site Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Adolescents and young adults (AYA) with sickle cell disease (SCD) encounter adverse health events during transition to adult care. While AYA with SCD face complex barriers to care, negative outcomes can be mitigated by the development of self-management behaviors. Self-Management for Youth Living with Sickle Cell Disease (SMYLS) is an application designed to improve SCD specific self-management, with promising results from feasibility studies. This paper describes the next stage of SMYLS, a multisite, hybrid type 1 effectiveness-implementation randomized controlled trial. Trial aims are to evaluate the effectiveness of the mHealth application, including the role of patient activation; assess potential for wide-scale implementation; and explore the impact of socioenvironmental and psychosocial factors on outcomes. There will be 272 AYA with SCD and their caregivers enrolled and randomized to control or intervention arm (1:1) after assessing activation level. The intervention arm will receive usual care and be encouraged to use the application daily for an initial intervention period and a later "booster" period, while the control arm will receive usual care plus a version of the application with SCD educational materials. Study aims will be evaluated using mixed methods (participant surveys at 1, 3, 6, 9, and 12 months and interviews with participants and providers/clinic administrators post-intervention). The SMYLS intervention has the potential to inform widescale adoption of a self-management intervention for AYA with SCD. The results may have broader applicability for conducting trials among youth with chronic illnesses facing similar barriers to care and for studying engagement in mHealth self-management interventions. Clinical trial registration number. NCT06035939.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.